Robert S. Palmer

944 total citations
17 papers, 325 citations indexed

About

Robert S. Palmer is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Robert S. Palmer has authored 17 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Robert S. Palmer's work include Peptidase Inhibition and Analysis (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Asthma and respiratory diseases (3 papers). Robert S. Palmer is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Asthma and respiratory diseases (3 papers). Robert S. Palmer collaborates with scholars based in Sweden, United States and United Kingdom. Robert S. Palmer's co-authors include Gunnar Cedersund, Cecilia Brännmark, Peter Strålfors, S.T. Glad, Alexandra Jauhiainen, Elin Nyman, Fredrik H. Nyström, Muir Russell, John Mo and Pablo Forte and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Clinical Pharmacology & Therapeutics.

In The Last Decade

Robert S. Palmer

17 papers receiving 300 citations

Peers

Robert S. Palmer
Jeong Soo Ahn South Korea
Gary L. Engelmann United States
David C. Grimsditch United Kingdom
L. М. Samokhodskaya Russia
Kathy Forrest United States
Mindi Zhao China
Yukiyo Ogata Japan
Margaret F. Veale Australia
Muhammad Jamaluddin Canada
Demin Yu China
Jeong Soo Ahn South Korea
Robert S. Palmer
Citations per year, relative to Robert S. Palmer Robert S. Palmer (= 1×) peers Jeong Soo Ahn

Countries citing papers authored by Robert S. Palmer

Since Specialization
Citations

This map shows the geographic impact of Robert S. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Palmer more than expected).

Fields of papers citing papers by Robert S. Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Palmer. The network helps show where Robert S. Palmer may publish in the future.

Co-authorship network of co-authors of Robert S. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Palmer. A scholar is included among the top collaborators of Robert S. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Palmer. Robert S. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhudenkov, Kirill, Robert S. Palmer, Alexandra Jauhiainen, et al.. (2021). Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling. International Journal of COPD. Volume 16. 101–111. 7 indexed citations
2.
Jirstrand, Mats, et al.. (2021). A stochastic mixed effects model to assess treatment effects and fluctuations in home‐measured peak expiratory flow and the association with exacerbation risk in asthma. CPT Pharmacometrics & Systems Pharmacology. 11(2). 212–224. 3 indexed citations
3.
4.
Asimus, Sara, Robert S. Palmer, Muna Albayaty, et al.. (2020). Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284. British Journal of Clinical Pharmacology. 86(7). 1398–1405. 9 indexed citations
5.
Palmer, Robert S., Jukka Mäenpää, Alexandra Jauhiainen, et al.. (2018). Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects. Clinical Pharmacology & Therapeutics. 104(6). 1155–1164. 76 indexed citations
6.
Gardiner, Philip, Alexandra Jauhiainen, Robert S. Palmer, et al.. (2017). Effect of CYP3A4 inhibitors verapamil and itraconazole on the pharmacokinetics of AZD7986, an oral DPP1 inhibitor. PA3977–PA3977. 1 indexed citations
7.
Stenvall, Kristina, John Mo, Philip Gardiner, et al.. (2017). Target engagement confirmed in man with a dipeptidyl peptidase 1 inhibitor. PA3251–PA3251. 3 indexed citations
8.
Tiger, Carl‐Fredrik, Gunnar Cedersund, Robert S. Palmer, et al.. (2012). A framework for mapping, visualisation and automatic model creation of signal‐transduction networks. Molecular Systems Biology. 8(1). 578–578. 43 indexed citations
9.
Nyman, Elin, Cecilia Brännmark, Robert S. Palmer, et al.. (2011). A Hierarchical Whole-body Modeling Approach Elucidates the Link between in Vitro Insulin Signaling and in Vivo Glucose Homeostasis. Journal of Biological Chemistry. 286(29). 26028–26041. 56 indexed citations
10.
Brännmark, Cecilia, Robert S. Palmer, S.T. Glad, Gunnar Cedersund, & Peter Strålfors. (2010). Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework. Journal of Biological Chemistry. 285(26). 20171–20179. 65 indexed citations
11.
Owen, John D., et al.. (1988). Hyperlipidemia and in vivo Hemostatic System Activation. Seminars in Thrombosis and Hemostasis. 14(3). 241–245. 9 indexed citations
12.
Palmer, Robert S.. (1960). Psychiatry and Internal Medicine. New England Journal of Medicine. 263(1). 14–18. 2 indexed citations
13.
Palmer, Robert S.. (1959). Treatment of hypertension. Journal of Chronic Diseases. 10(6). 500–512. 7 indexed citations
14.
Menninger, William C., et al.. (1958). More on homosexuality. Pastoral Psychology. 9(1). 46–49. 1 indexed citations
15.
Palmer, Robert S.. (1955). Essential Hypertension: A Selected Review and Commentary. New England Journal of Medicine. 252(22). 940–947. 4 indexed citations
16.
Palmer, Robert S.. (1953). COURSE AND PROGNOSIS OF ESSENTIAL HYPERTENSION. Journal of the American Medical Association. 153(1). 1–1. 27 indexed citations
17.
Palmer, Robert S., et al.. (1951). The Rice Diet in Ambulatory Patients with Essential Hypertension. New England Journal of Medicine. 244(16). 577–581. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeong Soo Ahn Breakdown of academic impact, for papers by Gary L. Engelmann Breakdown of academic impact, for papers by David C. Grimsditch Breakdown of academic impact, for papers by L. М. Samokhodskaya Breakdown of academic impact, for papers by Kathy Forrest Breakdown of academic impact, for papers by Mindi Zhao Breakdown of academic impact, for papers by Yukiyo Ogata Breakdown of academic impact, for papers by Margaret F. Veale Breakdown of academic impact, for papers by Muhammad Jamaluddin Breakdown of academic impact, for papers by Demin Yu
Rankless by CCL
2026